Published in Biochem Biophys Res Commun on September 26, 1972
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. Br J Cancer (2004) 1.37
Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models. Oncol Rep (2014) 1.30
Functional role of cysteine-146 in Escherichia coli thymidylate synthase. Proc Natl Acad Sci U S A (1988) 1.15
Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci U S A (1978) 1.11
Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. J Clin Invest (1975) 1.06
Thymidylate synthetase purified to homogeneity from human leukemic cells. Proc Natl Acad Sci U S A (1979) 1.04
Amino acid sequence at the FdUMP binding site of thymidylate synthetase. Proc Natl Acad Sci U S A (1976) 0.99
Bacteriophage T4 baseplate components. III. Location and properties of the bacteriophage structural thymidylate synthetase. J Virol (1975) 0.99
Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase. Proc Natl Acad Sci U S A (1979) 0.97
Sequence-specific and mechanism-based crosslinking of Dcm DNA cytosine-C5 methyltransferase of E. coli K-12 to synthetic oligonucleotides containing 5-fluoro-2'-deoxycytidine. Nucleic Acids Res (1993) 0.94
New challenges and inspired answers for anticancer drug discovery and development. Jpn J Clin Oncol (2013) 0.86
Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma. BMC Cancer (2012) 0.85
5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy. J Mater Sci Mater Med (2012) 0.83
Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer. Ann Surg (2004) 0.81
Pyrimidine nucleoside phosphorylase activity in tumour and matched normal gastrointestinal mucosa. Gut (1982) 0.79
A Fluorescent Probe to Measure DNA Damage and Repair. PLoS One (2015) 0.78
Promotion of purine nucleotide binding to thymidylate synthase by a potent folate analogue inhibitor, 1843U89. Proc Natl Acad Sci U S A (1995) 0.78
Incorporation of intermediary products of 5-FU anabolism into colorectal cancer. Gut (1986) 0.78
The cause of neural tube defects: some experiments and a hypothesis. J Med Genet (1983) 0.77
Relative level of thymidylate synthase mRNA expression in primary tumors and normal tissues predicts survival of patients with oral tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol (2009) 0.77
Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines. J Cancer Res Clin Oncol (2004) 0.76
Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer. Cancer Med (2013) 0.75
Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. Surg Today (2011) 0.75
A practical approach for assessing chemosensitivity in colorectal cancer cell lines by comparative analysis of cell viability and thymidylate synthase mRNA expression. J Korean Surg Soc (2011) 0.75
Analysis of the mRNA expression of chemotherapy-related genes in colorectal carcinoma using the danenberg tumor profile method. J Oncol (2013) 0.75
MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res (2000) 9.30
Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res (1973) 7.59
Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res (1973) 4.54
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res (1999) 3.66
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res (2000) 3.42
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res (1995) 3.04
Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer (1967) 3.04
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol (2001) 2.87
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
Chemical carcinogenesis. Annu Rev Biochem (1975) 2.70
Fluorinated pyrimidines. Prog Nucleic Acid Res Mol Biol (1965) 2.63
Thymidylate synthetase - a target enzyme in cancer chemotherapy. Biochim Biophys Acta (1977) 2.48
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol (2006) 2.34
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res (2001) 2.28
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
In vitro transformation of rodent cells by K-region derivatives of polycyclic hydrocarbons. Proc Natl Acad Sci U S A (1971) 2.21
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol (1996) 2.21
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol (1997) 2.19
Quantitative studies on the malignant transformation of mouse prostate cells by carcinogenic hydrocarbons in vitro. Int J Cancer (1969) 1.96
Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res (1999) 1.91
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res (1992) 1.91
High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res (1998) 1.68
Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells. Cancer Res (1976) 1.64
Mutagenicity to mammalian cells of epoxides and other derivatives of polycyclic hydrocarbons. Proc Natl Acad Sci U S A (1971) 1.61
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
Cancer chemotherapy with purine and pyrimidine analogues. Annu Rev Pharmacol (1967) 1.59
Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production. Virology (1975) 1.55
Fluorinated pyrimidines and their nucleosides. Adv Enzymol Relat Areas Mol Biol (1983) 1.54
In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate. Proc Natl Acad Sci U S A (1970) 1.53
Fluorinated pyrimidines. XXVI. Mammalian thymidylate synthetase: its mechanism of action and inhibition by fluorinated nucleotides. Mol Pharmacol (1965) 1.50
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (2000) 1.45
Malignant transformation in vitro by carcinogenic hydrocarbons. Science (1967) 1.41
Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res (1972) 1.33
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin Cancer Res (1998) 1.32
Transformation of C3H/10T1/2CL8 mouse embryo fibroblasts by ultraviolet irradiation and a phorbol ester. Nature (1976) 1.32
Chemical oncogenesis in culture. Adv Cancer Res (1973) 1.31
Transformation of hamster embryo cells by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res (1972) 1.25
An epoxide is an intermediate in the microsomal metabolism of the chemical carcinogen, dibenz(a,h)anthracene. Biochem Biophys Res Commun (1971) 1.24
Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res (2001) 1.23
Antigenicity of clones of mouse prostate cells transformed in vitro. Int J Cancer (1972) 1.21
Cell cycle dependency of oncogenic transformation induced by N-methyl-N'-nitro-N-nitrosoquanidine in culture. Cancer Res (1974) 1.20
The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine. Cancer Res (1972) 1.19
In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res (1982) 1.18
Effect of 5-fluoro- and 5-bromouracil substitution on the translation of human thymidylate synthase mRNA. J Biol Chem (1994) 1.18
Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 Cl 8 mouse fibroblasts. Proc Natl Acad Sci U S A (1979) 1.17
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene (2001) 1.17
Studies on the quantitative biology of hyperthermic killing of HeLa cells. Cancer Res (1973) 1.16
Liver homogenate-mediated mutagenesis in chinese hamster V79 cells by polycyclic aromatic hydrocarbons and aflatoxins. Mutat Res (1977) 1.13
Fluorinated pyrimidines. 38. The incorporation of 5-trifluoromethyl-2'-deoxyuridine into the deoxyribonucleic acid of vaccinia virus. Mol Pharmacol (1970) 1.13
Cultivation in vitro of cells derived from adult C3H mouse ventral prostate. J Natl Cancer Inst (1969) 1.13
Enhancement of X-ray transformation by 12-O-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Res (1978) 1.12
Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res (1983) 1.11
Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. Biochemistry (1974) 1.11
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res (1998) 1.10
Fluorinated pyrimidines. XXXVII. Effects of 5-trifluoromethyl-2'-deoxyuridine on the synthesis of deoxyribonucleic acid of mammalian cells in culture. Mol Pharmacol (1970) 1.10
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen. Clin Cancer Res (2001) 1.09
The mutagenicity to mammalian cells of pyrimidine nucleoside analogs. Mutat Res (1972) 1.07
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res (1999) 1.07
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials. Pharmacogenomics J (2011) 1.06
The binding of polycyclic aromatic hydrocarbons to the DNA, RNA, and proteins of transformable cells in culture. Cancer Res (1971) 1.05
Comparative studies of fluorinated pyrimidines with various cell lines. Cancer Res (1968) 1.04
Thymidylate synthetase purified to homogeneity from human leukemic cells. Proc Natl Acad Sci U S A (1979) 1.04
Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells. Cancer Res (1970) 1.03
Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase. Pharmacol Ther (1981) 1.03
In vitro malignant transformation of cells derid from mouse prostate in the presence of 3-methylcholanthrene. J Natl Cancer Inst (1969) 1.03
Binding of tritium-labeled polycyclic hydrocarbons to DNA of mouse skin. Cancer Res (1967) 1.02
Determination of the mutagenic activity to bacteriophage T4 of carcinogenic and noncarcinogenic compounds. Mol Pharmacol (1970) 1.02
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol (1998) 1.00
The effect of modifiers of microsomal enzymes on chemical oncogenesis in cultures of C3H mouse cell lines. Cancer Res (1976) 0.99
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res (1984) 0.99
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res (2000) 0.98
Incorporation of 5-fluorouracil into U2 and U6 snRNA inhibits mRNA precursor splicing. J Biol Chem (1994) 0.98
Effect of 5, 10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2'-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism. Biochemistry (1978) 0.98
Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase. Proc Natl Acad Sci U S A (1979) 0.97
Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons. Cancer Res (1970) 0.97
Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine. Chemotherapy (1976) 0.97
Kinetics and mechanism of interaction of 10-propargyl-5,8-dideazafolate with thymidylate synthase. J Med Chem (1986) 0.96
Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters. Cancer Res (1980) 0.95
Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase. Biochem Pharmacol (1981) 0.94
Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides. Cancer Res (1976) 0.94
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett (1997) 0.93
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. Dis Esophagus (2006) 0.93
Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. Proc Natl Acad Sci U S A (1979) 0.93
Isolation and degradation of DNA from cells treated with tritium-labeled 7,12-dimethylbenz(a)anthracene: studies on the nature of the binding of this carcinogen to DNA. Cancer Res (1969) 0.93
Human leukemic cells resistant to 5-fluoro-2'-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides. J Biol Chem (1983) 0.92
Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine. Cancer Res (1980) 0.92
Probabilistic view of the transformation of cultured C3H/10T1/2 mouse embryo fibroblasts by 3-methylcholanthrene. Proc Natl Acad Sci U S A (1980) 0.92
Mutagenesis of Chinese hamster cells is facilitated by thymidine and deoxycytidine. Nature (1978) 0.92
Influence of drugs and synchrony on the hyperthermic killing of HeLa cells. Cancer Res (1973) 0.92
Fluorinated pyrimidines. XLIV. Interaction of 5-trifluoromethyl-2'-deoxyuridine 5'-triphosphate with deoxyribonucleic acid polymerases. Mol Pharmacol (1973) 0.92
Metabolism of polycyclic aromatic hydrocarbons in cell cultuires. Cancer Res (1971) 0.91
Attempts to produce carcinogenesis in organ cultures of mouse prostate with polycyclic hydrocarbons. Int J Cancer (1967) 0.90
Fluorinated pyrimidines. XXVII. Attempts to determine transcription errors during the formation of fluorouracil-containing messenger ribonucleic acid. Biochemistry (1966) 0.90
Fluorinated pyrimidines. XL. The reduction of 5-fluorouridine 5'-diphosphate by ribonucleotide reductase. Mol Pharmacol (1972) 0.89
Evidence for a sequential interaction of the subunits of thymidylate synthetase. J Biol Chem (1979) 0.89
Breakdown of HeLa cell DNA mediated by vaccinia virus. Proc Natl Acad Sci U S A (1973) 0.89